The efficacy and toxicity of VAD in the treatment of myeloma and related disorders.
The efficacy and toxicity of VAD in the treatment of myeloma and related disorders.
复制标题
VAD 在治疗骨髓瘤及相关疾病中的功效和毒性。
DOI：
10.1111/j.1600-0609.1986.tb02632.x
复制
发表时间：
2009
期刊：
影响因子：
--
通讯作者：
A. Parker
中科院分区：
文献类型：
--
作者：
T. Sheehan;M. Judge;A. Parker
最近报道了29例晚期难治性骨髓瘤患者接受4-d阿曲库铵和阿霉素（VAD）输注治疗的令人印象深刻的结果。我们报告了我们自己的经验与此协议在13例骨髓瘤和相关的淋巴组织增生性疾病。在其中2例病例中，VAD被用作一线治疗。三分之二的病例出现了客观反应，治疗的主要并发症是感染，主要是细菌性感染。
Impressive results have recently been reported in 29 cases of advanced refractory myeloma treated with 4-d infusions of Vincristine and Adriamycin (VAD). We report our own experience with this protocol in 13 cases of myeloma and related lymphoproliferative disorders. In 2 of these cases, VAD was used as first line treatment. Objective responses were seen in two-thirds of cases and the major complication of therapy was infection, predominantly bacterial in nature.
影响因子：
158.5
作者：
BARLOGIE, B;SMITH, L;ALEXANIAN, R
通讯作者：
ALEXANIAN, R